Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-02 Dar Zavain Director Grant or award +1,907 108,132
2025-01-02 Li Dean Y Director Grant or award +1,647 77,350
2025-01-02 Borgeson Blake Director Grant or award +1,734 7,067,847
2024-12-19 Taylor Ben R Chief Financial Officer Grant or award +370,343 844,210
2024-12-19 Taylor Ben R Chief Financial Officer Grant or award · Stock Option (Right to Buy) +740,686 740,686
2024-12-17 Taylor Ben R Chief Financial Officer Shares withheld for taxes −7,057 $6.95 $49K 473,867
2024-12-16 Taylor Ben R Chief Financial Officer Shares withheld for taxes −15,668 $6.04 $95K 480,924
2024-12-05 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +20,000 756,633
2024-12-05 Gibson Christopher Chief Executive Officer Sale 10b5-1 −20,000 $7.12 $142K 736,633
2024-12-05 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −20,000 6,016,700
2024-12-04 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +20,000 756,633
2024-12-04 Gibson Christopher Chief Executive Officer Sale 10b5-1 −20,000 $7.16 $143K 736,633
2024-12-04 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −20,000 6,036,700
2024-11-20 Michor Franziska Director Grant or award +30,618 30,618
2024-11-20 Michor Franziska Director Grant or award +15,335 45,953
2024-11-20 Michor Franziska Director Grant or award +17,694 63,647
2024-11-20 Michor Franziska Director Grant or award +41,390 105,037
2024-11-20 Michor Franziska Director Grant or award · Stock Option (Right to Buy) +30,670 30,670
2024-11-20 Michor Franziska Director Grant or award · Stock Option (Right to Buy) +15,286 15,286
2024-11-20 Michor Franziska Director Grant or award · Stock Option (Right to Buy) +17,694 17,694

Page 12 of 41 · 805 trades